Skip to main content
Premium Trial:

Request an Annual Quote

Predicant Biosciences Acquires Pathwork Informatics With VC Cash, Renames Firm

NEW YORK (GenomeWeb News) - Predicant Biosciences acquired San Jose, Calif.-based Pathwork Informatics with venture capital funding and renamed the company Pathwork Diagnostics, the new corporation said today.
The new company is backed with $11 million from Prospect Venture Partners, Advent Venture Partners, Novus Ventures, Venrock Associates, and Versant Ventures.
Predicant CEO Deborah Neff will be Pathwork Diagnostics' president and CEO. Glenda Anderson, founder and CEO of Pathwork Informatics, will be the new firm's chief technology officer.

The combined company's first product will be a test to help diagnose the origin of secondary and unspecified malignant cancers.

Financial details were not disclosed.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.